Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2010
12/23/2010US20100324017 Acylguanidine derivative
12/23/2010US20100324010 Amide compounds and use of the same
12/23/2010US20100324001 Novel Methods for the Treatment of Inflammatory Diseases
12/23/2010US20100322980 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
12/23/2010CA2765534A1 Small molecule inhibitors of spleen tyrosine kinase (syk)
12/23/2010CA2765015A1 Deuterated isoindoline-1,3-dione derivatives as pde4 and tnf-alpha inhibitors
12/23/2010CA2764541A1 Fungicidal mixtures
12/23/2010CA2763960A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010CA2762512A1 Triazole compounds carrying a sulfur substituent
12/23/2010CA2762304A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
12/22/2010EP2265092A1 Electroluminescent device
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
12/22/2010EP2264029A1 1,3-dihydroisobenzofuran derivative
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264009A1 Pyridylaminoacetic acid compound
12/22/2010EP2264008A1 Substituted enaminocarbonyl compounds
12/22/2010EP2262798A2 Substituted enaminothiocarbonyl compounds
12/22/2010EP2262797A1 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
12/22/2010EP2262789A1 2-aminoquinolines
12/22/2010EP2262785A1 Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
12/22/2010EP2262774A2 2-aminoquinolines
12/22/2010EP2262773A1 2-aminoquinoline derivatives
12/22/2010EP2262772A1 Quinoline derivatives as axl kinase inhibitors
12/22/2010EP2262767A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP1943230B1 Compounds which have activity at m1 receptor and their uses in medicine
12/22/2010EP1453805B1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/22/2010CN1988907B Dual small molecule inhibitors of cancer and angiogenesis
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1802366B C-glycoside derivatives and salts thereof
12/22/2010CN101925596A Beta-amino acid derivatives for treatment of diabetes
12/22/2010CN101925595A Phthalazinone derivatives
12/22/2010CN101925590A Aldh-2 inhibitors in treatment of addiction
12/22/2010CN101925588A 2-cyanophenyl sulfonamide derivatives useful as pesticides
12/22/2010CN101921256A Diphenyl pyrone amide derivative and preparation method and application thereof
12/22/2010CN101921238A Preparation of substituted nitrogen-containing benzoheterocycle derivatives and pharmacological application thereof
12/22/2010CN101921236A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/22/2010CN101921232A Salt of 2-ring substituted pyrazolone azo derivatives, and preparation method and application thereof in medicaments
12/22/2010CN101440087B Phthalimide diglycidyl ether and preparation thereof
12/22/2010CN101128436B Glycine derivative and use thereof
12/22/2010CN101001836B Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
12/21/2010US7855298 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
12/21/2010US7855297 Amide derivatives and medicinal use thereof
12/21/2010US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010US7855207 such as 6-[(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-piperidin-1-ylpropyl]-3-ethyl-1H-quinolin-2-one, used for treating cancer and/or preventing cellular, tissue and/or organ damage resulting from cell damage or death due to, for example, necrosis or apoptosis
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010US7855193 1-(4-(5-Phenylbenzofuran-2-yl)benzyl)azetidine-3-carboxylic acids; anticarcinogenic, antiinflammatory, antiarthritic, antidiabetic agents; transplant rejection, autoimmune diseases, lupus, multiple sclerosis, psoriasis, inflammatory bowel disease, Chron's disease
12/21/2010CA2659682C Prolyl hydroxylase inhibitors and methods of use
12/21/2010CA2569654C Benzimidazolone carboxylic acid derivatives
12/21/2010CA2532067C N-methyle-substituted benzamidazoles
12/21/2010CA2483461C Isoquinoline derivatives
12/21/2010CA2483345C Imidazolinylmethyl aralkylsulfonamides
12/21/2010CA2457575C 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
12/21/2010CA2452596C Benzo-fused 5-membered heterocyclic compounds, their production and use
12/21/2010CA2397981C Azacyclic compounds for use in the treatment of serotonin related diseases
12/19/2010CA2669877A1 Benzofuran-3-yl-(indol-3-yl)maleimides as potent gsk3 inhibitors
12/16/2010WO2010143733A1 Novel fused cyclic compound and use thereof
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010142801A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010WO2010142735A1 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
12/16/2010WO2010142137A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
12/16/2010WO2010122580A3 Piperidine derivatives as inhibitors of renin
12/16/2010WO2010116088A3 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
12/16/2010WO2010052569A3 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/16/2010US20100317871 Method for the preparation of darifenacin hydrogen bromide
12/16/2010US20100317842 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry
12/16/2010US20100317669 Novel substituted piperidyl-propane-thiols
12/16/2010US20100317660 Mediators of hedgehog signaling pathways, compositions and uses related thereto
12/16/2010US20100317612 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition
12/16/2010US20100317515 Azolylmethyloxiranes, use Thereof and Agents Containing the Same
12/16/2010US20100316601 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
12/16/2010US20100314615 Aromatic amine derivative and organic electroluminescent device using the same
12/16/2010CA2847910A1 Anti-viral compounds
12/16/2010CA2765181A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010CA2765044A1 Benzyl substituted triazine derivatives and their therapeutical applications
12/16/2010CA2765030A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764694A1 Pyridinyl derivatives asinhibitors of enzyme nicotinamide phosphoribosyltransferase
12/16/2010CA2764653A1 Tetracyclic compounds
12/16/2010CA2763717A1 Pyrimidine derivatives as zap-70 inhibitors
12/16/2010CA2762916A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
12/15/2010EP2261223A1 Pyrimidine derivatives used as pi-3 kinase inhibitors
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261216A2 Pyrazoles as glucokinase activators
12/15/2010EP2261211A1 1,4-dihydropyridine derivatives and their uses
12/15/2010EP2261206A1 Indolinone compound
12/15/2010EP2260051A1 Glucopyranoside derivatives
12/15/2010EP2260025A2 Specific impurities of montelukast
12/15/2010EP2260020A1 Hydroxamate-based inhibitors of deacetylases b
12/15/2010EP2000465B1 Triazolone derivative
12/15/2010EP1740578B1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1411954B1 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN1909909B 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
12/15/2010CN1882567B Quinazoline derivatives as tyrosine kinase inhibitors
12/15/2010CN101918402A Octahydroquinoli zines for antidiabetic treatment
12/15/2010CN101918392A Pyrazole derivatives as 5-LO inhibitors
1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 694